India's NHM Webinar Series could become a key platform for improving public health across the country.
India’s pharmaceutical sector witnessed a dynamic week marked by drug innovation, regulatory tightening, global collaborations, and infrastructure investments
India has marked a significant milestone in global eye care as the WHO redesignates the L V Prasad Eye Institute as the Centre for Prevention of Blindness until 2030
India’s healthcare ecosystem is witnessing a steady transformation, driven by rising research and development (R&D) initiatives and increased investments in scientific infrastructure
Godavari Biorefineries has achieved a milestone in the global battle against cancer with the Japanese patenting of its anti-cancer molecule
India's medical device industry is on track for a major transformation. A new report by Bain & Company says the sector could unlock a USD 35 billion opportunity by 2030, making it one of the fastest-growing segments of India's healthcare ecosystem.
India is set to become one of the earliest markets for Novo Nordisk's breakthrough once-weekly insulin,The Danish drug maker is preparing to launch Awiqli after securing regulatory approval.
Marksans Pharma has taken another step to expand its Europe presence by signing a deal to acquire Germany-based ABCnow GmbH.
AI healthcare growth is turning India into one of the world's biggest centers for medical technology innovation.
Researchers have developed a new one injection treatment that could reduce the need for osteoarthritis surgery in the future.
, CDSCO.jpg)